LSTA FY 2006 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2006 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$45,724+29.7% YoY

Gross Profit

$23,32651.0% margin

Operating Income

-$5M-10259.4% margin

Net Income

-$6M-13233.8% margin

EPS (Diluted)

$-4369.24

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1M

Total Liabilities

$902,869

Stockholders' Equity

$292,105

Cash & Equivalents

$436,659

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45,724	$35,262	+29.7%
Gross Profit	$23,326	$10,486	+122.4%
Operating Income	-$5M	-$2M	-193.0%
Net Income	-$6M	-$2M	-246.8%